Renaissance Technologies's ADPT Position Overview
Renaissance Technologies (via Renaissance Technologies LLC) currently holds 279,700 shares of Adaptive Biotechnologies Corporation (ADPT) worth $4.18 M, representing 0.01% of the portfolio. First purchased in 2021-Q1, this medium-term investment has been held for 19 quarters.
Based on 13F filings, Renaissance Technologies has maintained a strategic position in ADPT, demonstrating sustained confidence in this investment. Largest addition occurred in Q1 2022, adding 295,400 shares. Largest reduction occurred in Q3 2023, reducing 287,300 shares.
Analysis based on 13F filings available since 2013 Q2
Renaissance Technologies's Adaptive Biotechnologies Corporation (ADPT) Holding Value Over Time
Track share changes against reported price movement
Quarterly Adaptive Biotechnologies Corporation (ADPT) Trades by Renaissance Technologies
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2021 | +160,200 | New Buy | 160,200 | $40.26 |
| Q2 2021 | -160,200 | Sold Out | 160,200 | $0.00 |
| Q1 2022 | +455,600 | New Buy | 455,600 | $13.88 |
| Q2 2022 | +30,900 | Add 6.78% | 486,500 | $8.09 |
| Q3 2022 | -28,700 | Reduce 5.90% | 457,800 | $7.12 |
| Q4 2022 | -42,000 | Reduce 9.17% | 415,800 | $0.01 |
| Q1 2023 | -21,800 | Reduce 5.24% | 394,000 | $0.01 |
| Q2 2023 | -55,500 | Reduce 14.09% | 338,500 | $0.01 |
| Q3 2023 | -287,300 | Reduce 84.87% | 51,200 | $5.45 |
| Q4 2023 | -51,200 | Sold Out | 51,200 | $0.00 |
| Q1 2024 | +52,583 | New Buy | 52,583 | $3.21 |
| Q2 2024 | +99,217 | Add 188.69% | 151,800 | $3.62 |
| Q3 2024 | +17,600 | Add 11.59% | 169,400 | $5.12 |
| Q4 2024 | +60,385 | Add 35.65% | 229,785 | $5.99 |
| Q1 2025 | -123,900 | Reduce 53.92% | 105,885 | $7.43 |
| Q2 2025 | -55,985 | Reduce 52.87% | 49,900 | $11.65 |
| Q3 2025 | +229,800 | Add 460.52% | 279,700 | $14.96 |
Renaissance Technologies's Adaptive Biotechnologies Corporation Investment FAQs
Renaissance Technologies first purchased Adaptive Biotechnologies Corporation (ADPT) in Q1 2021, acquiring 160,200 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Renaissance Technologies has held Adaptive Biotechnologies Corporation (ADPT) for 19 quarters since Q1 2021. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Renaissance Technologies's largest addition to Adaptive Biotechnologies Corporation (ADPT) was in Q1 2022, adding 455,600 shares worth $6.32 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
According to the latest 13F filing for Q3 2025, Renaissance Technologies's firm, Renaissance Technologies LLC, owns 279,700 shares of Adaptive Biotechnologies Corporation (ADPT), valued at approximately $4.18 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
As of the Q3 2025 filing, Adaptive Biotechnologies Corporation (ADPT) represents approximately 0.01% of Renaissance Technologies's publicly disclosed stock portfolio, making it one of their key holdings. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Renaissance Technologies's peak holding in Adaptive Biotechnologies Corporation (ADPT) was 486,500 shares, as reported at the end of Q2 2022. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.